ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1
4 August 2022 at 08:00
Oncogenesis, Published online: 04 August 2022; doi:10.1038/s41389-022-00418-2
ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1